glp 1 and dental health Beyond Ozempic breath: A U of T Dentistry researcher examines GLP-1s oral GLP-1 medications cause dental issues

Pharmacological intervention and therapeutic strategies aimed to modify brain RBC molecular signatures have been identified and are greatly promising

However, we know that is not the full story

Dimethylarginine dimethylaminohydrolase overexpression enhances insulin sensitivity

Authors noted marked heterogeneity of analyzed data and included older cohorts meaning that advances in PD including availability of icodextrin, and low-GDP neutral pH fluids are not reflected in all studies.8 This has also been supported by another Asian review and meta-analysis, outlining diabetes, among others, as a risk factor for mortality in PD patients.9 Increased CV mortality in diabetic PD patients with metabolic syndrome when compared to HD has been suggested by a recent meta-analysis (8 observational studies, n=790 patients on KRT)

S1C, GLP-1RAs intervention was associated with a reduction in body weight when compared to metformin (MD = 3.82